Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,431,633
-
Share change
-
+864,604
-
Total reported value
-
$17,489,372
-
Put/Call ratio
-
63%
-
Price per share
-
$0.96
-
Number of holders
-
77
-
Value change
-
+$1,256,162
-
Number of buys
-
36
-
Number of sells
-
20
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q3 2020
As of 30 Sep 2020,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,431,633 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., CVA Family Office, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Western Wealth Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, GROUP ONE TRADING, L.P., SRS Capital Advisors, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, and FIRST TRUST ADVISORS LP.
This page lists
77
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.